Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 7(8): e44326, 2012.
Article in English | MEDLINE | ID: mdl-22952955

ABSTRACT

The most feared complication following intestinal resection is anastomotic leakage. In high risk areas (esophagus/rectum) where neoadjuvant chemoradiation is used, the incidence of anastomotic leaks remains unacceptably high (≈ 10%) even when performed by specialist surgeons in high volume centers. The aims of this study were to test the hypothesis that anastomotic leakage develops when pathogens colonizing anastomotic sites become in vivo transformed to express a tissue destroying phenotype. We developed a novel model of anastomotic leak in which rats were exposed to pre-operative radiation as in cancer surgery, underwent distal colon resection and then were intestinally inoculated with Pseudomonas aeruginosa, a common colonizer of the radiated intestine. Results demonstrated that intestinal tissues exposed to preoperative radiation developed a significant incidence of anastomotic leak (>60%; p<0.01) when colonized by P. aeruginosa compared to radiated tissues alone (0%). Phenotype analysis comparing the original inoculating strain (MPAO1- termed P1) and the strain retrieved from leaking anastomotic tissues (termed P2) demonstrated that P2 was altered in pyocyanin production and displayed enhanced collagenase activity, high swarming motility, and a destructive phenotype against cultured intestinal epithelial cells (i.e. apoptosis, barrier function, cytolysis). Comparative genotype analysis between P1 and P2 revealed a single nucleotide polymorphism (SNP) mutation in the mexT gene that led to a stop codon resulting in a non-functional truncated protein. Replacement of the mutated mexT gene in P2 with mexT from the original parental strain P1 led to reversion of P2 to the P1 phenotype. No spontaneous transformation was detected during 20 passages in TSB media. Use of a novel virulence suppressing compound PEG/Pi prevented P. aeruginosa transformation to the tissue destructive phenotype and prevented anastomotic leak in rats. This work demonstrates that in vivo transformation of microbial pathogens to a tissue destroying phenotype may have important implications in the pathogenesis of anastomotic leak.


Subject(s)
Anastomotic Leak/microbiology , Intestines/microbiology , Mutation/genetics , Polymorphism, Single Nucleotide/genetics , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/pathogenicity , Anastomosis, Surgical/adverse effects , Anastomotic Leak/pathology , Animals , Apoptosis/drug effects , Base Sequence , Caenorhabditis elegans , Colon/drug effects , Colon/metabolism , Colon/pathology , Intestines/drug effects , Intestines/pathology , Intestines/ultrastructure , Male , Molecular Sequence Data , Phenotype , Phosphates/pharmacology , Polyethylene Glycols/pharmacology , Protective Agents/pharmacology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/isolation & purification , Radiation , Rats , Rats, Wistar , Tight Junctions/drug effects , Tight Junctions/metabolism , Wound Healing/drug effects , Zonula Occludens-1 Protein/metabolism
2.
Antimicrob Agents Chemother ; 50(9): 3070-4, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16940103

ABSTRACT

Human immunodeficiency virus (HIV) transmission through saliva is extremely low. Several oral components, including secretory immunoglobulin A and secretory leukocyte protease inhibitor, are known as potential inhibitory agents of HIV oral transmission. Here we examined anti-HIV activity of oral bacterial components. We showed that recombinant protein HGP44 derived from Porphyromonas gingivalis, one of the primary infectious agents of periodontitis, was capable of inhibiting HIV type 1 (HIV-1) replication. HGP44 bound specifically to HIV-1 gp120 and blocked HIV-1 envelope-mediated membrane fusion. These findings suggest that HGP44 of P. gingivalis can inhibit HIV-1 infection by blocking HIV-1 entry.


Subject(s)
Adhesins, Bacterial/pharmacology , Antiviral Agents/pharmacology , Cysteine Endopeptidases/pharmacology , HIV-1/physiology , Peptide Fragments/pharmacology , Porphyromonas gingivalis/enzymology , Adhesins, Bacterial/isolation & purification , Animals , Binding Sites , COS Cells , Chlorocebus aethiops , Cysteine Endopeptidases/isolation & purification , Gingipain Cysteine Endopeptidases , HIV Envelope Protein gp120/metabolism , HIV Infections/prevention & control , HIV Infections/virology , HIV-1/pathogenicity , Humans , Protein Structure, Tertiary , Virus Replication/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...